The Significance of Arrhythmias in Athletes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Assaf-Harofeh Medical Center.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Institute of Physical Education and Sports Sciences
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT00469794
First received: May 4, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

Athletes with complex ventricular arrhythmias are potentially at risk of sudden death. The aim of the study is to investigate the relevance of ventricular tachyarrhythmias induced by an exercise test in a retrospectively evaluated athletic population.


Condition Intervention
Sudden Death
Procedure: stress test

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Longitudinal
Official Title: The Long Term Significance of Exercise Induced Ventricular Arrhythmias in Trained Athletes

Resource links provided by NLM:


Further study details as provided by Assaf-Harofeh Medical Center:

Estimated Enrollment: 300
Study Start Date: May 2006
Estimated Study Completion Date: May 2008
Detailed Description:

Athletes with complex ventricular arrhythmias are potentially at risk of sudden death. The risk is increased when the athletes are engaged in competitive activities.

Ventricular premature beats (VPB’s) are a common finding in the athletic heart. In the majority of cases these arrhythmias are part of the “athlete’s heart syndrome” and do not increase the risk of sudden death in the athletes with an apparently normal heart. The data available in the literature deal with ventricular arrhythmias assessed only by 24-h ambulatory electrocardiograms.

To date, there are no guidelines concerning athletes who develop ventricular arrhythmias during a stress test. It is unclear whether they should be allowed to continue with their competitive activity or they should be denied to do so. A study looking at the long term follow-up of these athletes will help us determine whether the development of ventricular arrhythmia during a stress test imposes any risk on the athletes.

  Eligibility

Ages Eligible for Study:   10 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Competitive athletes less than 35 YO
  • Competitive athletes with ventricular arrhythmias on baseline or recovery in a stress test
  • Competitive athletes with ventricular arrhythmia during exercise

Exclusion Criteria:

  • Athletes who don’t meet the exclusion criteria.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00469794

Contacts
Contact: Therese Fuchs, MD 972-8-977-9730 therese@fuchs.org
Contact: Zvi Vered, MD 972-8-977-9735 zvered@asaf.health.gov.il

Locations
Israel
Wingate Institute Recruiting
Netanya, Israel
Contact: Therese Fuchs, MD    972-8-977-9730    therese@fuchs.org   
Sub-Investigator: Rutie Plitz-Burstein, Ph.D.         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Institute of Physical Education and Sports Sciences
Investigators
Principal Investigator: Therese Fuchs, MD Assaf-Harofeh Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00469794     History of Changes
Other Study ID Numbers: 50/06
Study First Received: May 4, 2007
Last Updated: May 4, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:
arrhythmias
Athletes
exercise

Additional relevant MeSH terms:
Arrhythmias, Cardiac
Death, Sudden
Heart Diseases
Cardiovascular Diseases
Pathologic Processes
Death

ClinicalTrials.gov processed this record on July 28, 2014